ArticleFrontiers in immunology2026
Efficacy and safety of modified-dose obinutuzumab in the treatment of refractory membranous nephropathy.
Jiannan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it